Literature DB >> 25847472

Development and validation of a clinical scale for rating the severity of blepharospasm.

Giovanni Defazio1, Mark Hallett, Hyder A Jinnah, Glenn T Stebbins, Angelo F Gigante, Gina Ferrazzano, Antonella Conte, Giovanni Fabbrini, Alfredo Berardelli.   

Abstract

Existing scales for rating the severity of blepharospasm (BSP) are limited by a number of potential drawbacks. We therefore developed and validated a novel scale for rating the severity of BSP. The development of the scale started with careful examination of the clinical spectrum of the condition by a panel of experts who selected phenomenological aspects thought to be relevant to disease severity. Thereafter, selected items were first checked for reliability, then reliable items were combined to generate the scale, and clinimetric properties of the scale were evaluated. Finally, the confidence with which the scale could be used by people without high levels of movement disorders skill was assessed. The new scale, based on objective criteria, yielded moderate to almost perfect reliability, acceptable internal consistency, satisfactory scaling assumptions, lack of floor and ceiling effects, partial correlations with a prior severity scale and with a quality of life scale, and good sensitivity to change. Despite a few limitations, the foregoing features make the novel scale more suitable than existing scales to assess the severity of BSP in natural history and pathophysiologic studies as well as in clinical trials.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Blepharospasm; Blinking; Dystonia; rating scale; severity

Mesh:

Year:  2015        PMID: 25847472      PMCID: PMC4878674          DOI: 10.1002/mds.26156

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  Assessing health status and quality-of-life instruments: attributes and review criteria.

Authors:  Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

Review 2.  Update on blepharospasm: report from the BEBRF International Workshop.

Authors:  Mark Hallett; Craig Evinger; Joseph Jankovic; Mark Stacy
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

3.  Rating scales for dystonia: a multicenter assessment.

Authors:  Cynthia L Comella; Sue Leurgans; Joanne Wuu; Glenn T Stebbins; Teresa Chmura
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

Review 4.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

5.  Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.

Authors:  J Müller; J Wissel; G Kemmler; B Voller; T Bodner; A Schneider; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 6.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

7.  Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".

Authors:  Margherita Fabbri; Maria Superbo; Giovanni Defazio; Cesa Lorella Maria Scaglione; Elena Antelmi; Giacomo Basini; Stefania Nassetti; Fabio Pizza; Rosaria Plasmati; Rocco Liguori
Journal:  Neurol Sci       Date:  2014-01-30       Impact factor: 3.307

8.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

9.  Is increased blinking a form of blepharospasm?

Authors:  Antonella Conte; Giovanni Defazio; Gina Ferrazzano; Mark Hallett; Antonella Macerollo; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Neurology       Date:  2013-06-11       Impact factor: 9.910

10.  Validity and reliability of a rating scale for the primary torsion dystonias.

Authors:  R E Burke; S Fahn; C D Marsden; S B Bressman; C Moskowitz; J Friedman
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

View more
  19 in total

1.  BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm.

Authors:  Vasileios Siokas; Dimitrios Kardaras; Athina-Maria Aloizou; Ioannis Asproudis; Konstadinos G Boboridis; Eleni Papageorgiou; Georgios M Hadjigeorgiou; Evangelia E Tsironi; Efthimios Dardiotis
Journal:  Neuromolecular Med       Date:  2018-12-05       Impact factor: 3.843

2.  INCREASED BLINKING MAY BE A PRECURSOR OF BLEPHAROSPASM: A LONGITUDINAL STUDY.

Authors:  Antonella Conte; Gina Ferrazzano; Giovanni Defazio; Giovanni Fabbrini; Mark Hallett; Alfredo Berardelli
Journal:  Mov Disord Clin Pract       Date:  2017-06-02

Review 3.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

Review 4.  Cannabinoids and dystonia: an issue yet to be defined.

Authors:  Marcello Mario Mascia; Daniele Carmagnini; Giovanni Defazio
Journal:  Neurol Sci       Date:  2019-12-17       Impact factor: 3.307

5.  Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications.

Authors:  Gina Ferrazzano; Isabella Berardelli; Antonella Conte; Viola Baione; Cristina Concolato; Daniele Belvisi; Giovanni Fabbrini; Giovanni Defazio; Alfredo Berardelli
Journal:  J Neurol       Date:  2019-07-29       Impact factor: 4.849

6.  A trial of a mechanical device for the treatment of blepharospasm.

Authors:  Alexina Fantato; Manoj Parulekar; John Elston
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

7.  Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.

Authors:  Gina Ferrazzano; Antonella Muroni; Antonella Conte; Tommaso Ercoli; Giorgio Tamburini; Giovanni Fabbrini; Alfredo Berardelli; Giovanni Defazio
Journal:  Mov Disord Clin Pract       Date:  2020-09-22

8.  Soft Nanomembrane Sensors and Flexible Hybrid Bioelectronics for Wireless Quantification of Blepharospasm.

Authors:  Musa Mahmood; Shinjae Kwon; Gamze Kilic Berkmen; Yun-Soung Kim; Laura Scorr; H A Jinnah; Woon-Hong Yeo
Journal:  IEEE Trans Biomed Eng       Date:  2020-02-21       Impact factor: 4.538

Review 9.  Treatment of Blepharospasm/Hemifacial Spasm.

Authors:  Kemar E Green; David Rastall; Eric Eggenberger
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

10.  Objective, computerized video-based rating of blepharospasm severity.

Authors:  David A Peterson; Gwen C Littlewort; Marian S Bartlett; Antonella Macerollo; Joel S Perlmutter; H A Jinnah; Mark Hallett; Terrence J Sejnowski
Journal:  Neurology       Date:  2016-10-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.